Paindrainer AB presented as one of the awards nominees for the prestigious Prix Galien Bridges 2026
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB, is proud to be selected as one of the awards nominees for the esteemed Prix Galien Bridges 2026 awards. Paindrainer has been selected as a nominee in the category for best medical technology. The outcome will be presented on dec 1st 2026 at the Prix Galien gala in Stockholm.
The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, founded in 1970, awards innovative companies within health care for outstanding performance in their field. The Prix Galien award is considered the equivalent to the Nobel price in the biopharmaceutical research field. Paindrainer’s nomination as a finalist in the category for best medical technology validates the company’s uniqueness in this field.
”Being a finalist in the Prix Galien bridges awards is a tremendous honor and a testament to our unique digital solution for self-management of chronic pain and our team’s dedication to innovative solutions in health technology. This truly shows that the hard work the team has done the recent years presents real value to both patients and the healthcare system. We look forward to the gala in December,” says Erik Frick, CEO Paindrainer AB.
To qualify, each candidate must demonstrate a significant advancement or novel approach that meaningfully improves patient outcomes, healthcare delivery, or scientific understanding. The formal awards ceremony, which follows the annual Prix Galien Bridges Forum, will take place on December 1, 2026, at the Medicinska Föreningen at Karolinska Institutet in Stockholm, Sweden.